Plasmacure
Plasmacure is a Dutch medical device company that develops PLASOMA, a CE-certified cold plasma system using Dual Plasma technology to treat chronic wounds such as diabetic foot ulcers and venous leg ulcers in hospitals, wound care clinics, and home settings.
- Company typePrivate
- Founded2015
- HeadquartersEindhoven, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Plasmacure does
Plasmacure B.V. is a Dutch medical technology company, headquartered in Nijmegen with R&D at the High Tech Campus in Eindhoven, that has developed PLASOMA, a CE-certified cold plasma medical device for the treatment of chronic and complex wounds including diabetic foot ulcers and venous leg ulcers. The company originated at the Technical University Eindhoven (TU/e) and serves hospitals, wound care clinics, and home-care settings treating the 5-10% of elderly patients globally who are affected by complex wounds and who represent 2-4% of healthcare budgets. The PLASOMA system applies "Dual Plasma" technology that combines cold plasma (controlled electrical discharge in air) with mild electrostimulation to support the body's natural healing process; the device is supported by a randomized clinical trial showing 2.5x more complex wounds closed versus standard wound care. Plasmacure holds ISO 13485:2016 quality certification and CE marking, has built clinical and scientific partnerships with entities including St. Antonius Hospital, the Dutch Burns Foundation, EWMA, Diabetes Fonds, and TU/e, and is pursuing U.S. FDA approval.
Plasmacure generates revenue primarily through hardware sales of the PLASOMA system (Pulser and associated consumables such as cold plasma pads), supplemented by recurring service and maintenance contracts and rental/try-out arrangements, priced on a quote-based multi-year contract basis. Its go-to-market is sales-led and enterprise-focused: a Business Development Manager drives direct sales to Dutch healthcare providers and wound care centers, while international expansion runs through distributor partnerships supported by a Marketing Manager-led enablement program. The product currently carries a "Promising Care" (Veelbelovende Zorg) designation in the Netherlands, meaning it is not yet covered by standard insurance reimbursement, and the company is actively working with Dutch insurer Coöperatie VGZ (also an investor) toward broader coverage. Capital structure is venture-backed, with investors including Venture Medical (US), Noaber, NXG Ventures, Oost NL, the European Innovation Council, and VGZ; cumulative disclosed funding is roughly €14.5M, anchored by a July 2025 €6M Series A led by Venture Medical and an additional €8.5M+ US go-to-market tranche.
Plasmacure firmographics
Firmographics- Name
- Plasmacure
- Legal name
- PlasmaCure B.V.
- Website
- https://plasmacure.nl
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Plasmacure is a Dutch medical device company that develops PLASOMA, a CE-certified cold plasma system using Dual Plasma technology to treat chronic wounds such as diabetic foot ulcers and venous leg ulcers in hospitals, wound care clinics, and home settings.
- Ownership category
- akta.pro rank
Plasmacure industry classification
Industry- Product category
- Advanced Wound Care Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Wound Care & Ulcer Management (HLAKACAN)
Keywords
Where Plasmacure is headquartered
LocationHeadquarters
- HQ city
- Eindhoven
- HQ country
- Netherlands
- HQ region
- Europe
Offices3 records
Markets served
Plasmacure business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- PLASOMA Medical Device Sales: Sale of PLASOMA system including the PLASOMA Pulser and associated components for wound treatment in healthcare settings.
- Service and Maintenance: Service and maintenance contracts for PLASOMA system. Customer responsible for organizing maintenance unless separate service contract agreed with Plasmacure.
- Rental/Try-out: Rental and try-out arrangements for PLASOMA Goods. Rental Goods remain property of Plasmacure. Customer uses Goods on its own behalf following instructions of use.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | PLASOMA System - Medical device for chronic wound treatment |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Plasmacure product offering
Product offeringCore offering
Plasmacure develops and sells PLASOMA, a CE-certified medical device that uses Dual Plasma technology — combining cold plasma (controlled electrical discharge in air) with mild electrostimulation — to accelerate healing of chronic and complex wounds such as diabetic foot ulcers and venous leg ulcers in clinical and home-care settings. The offering is complemented by consumable cold plasma pads, service/maintenance contracts, and rental/try-out arrangements, sold primarily to healthcare providers, wound care centers, and through international distributors.
Product overview
Plasmacure offers a single unified product — the PLASOMA System — which is a cold plasma medical device for wound care. PLASOMA applies Dual Plasma technology combining cold plasma and mild electrostimulation to accelerate natural wound healing. The product portfolio includes the core PLASOMA medical device (Pulser) and associated consumables such as cold plasma pads. Plasmacure also provides related services including maintenance, clinical affairs support, and application support for healthcare professionals. The company has received "Promising Care" designation in the Netherlands and is working toward broader reimbursement.
Differentiator
Problem solved
Functional benefit
Brands
- PLASOMA: CE-certified medical device for the treatment of chronic and complex wounds using cold plasma technology combined with mild electrostimulation to accelerate natural wound healing.
Products and services
- PLASOMA A CE-certified medical device that applies Dual Plasma technology — combining cold plasma and mild electrostimulation — to support the body's natural wound healing process for chronic and complex wounds such as diabetic foot ulcers and venous leg ulcers. Designed for use by healthcare providers in clinical settings and supported by consumable cold plasma pads and accessory components.
- PLASOMA Service & Maintenance Contracts Service and maintenance contracts for the PLASOMA system. By default, customers are responsible for organizing maintenance of the device unless a separate service contract is agreed with Plasmacure, providing optional ongoing technical support.
- PLASOMA Rental / Try-out Arrangements Rental and try-out arrangements for PLASOMA devices, allowing healthcare providers to evaluate the system before purchase. Rental goods remain the property of Plasmacure, with customers using the devices on their own behalf following the instructions of use.
Quantifiable outcome
- 2.5x more complex wounds closed than standard wound care
- +3 more outcomes
Companies that use Plasmacure
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Plasmacure technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Plasmacure partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- TU/e (Technical University Eindhoven)corePlasmacure originated at TU/e and has grown through strong network of scientific partners. Innovation partner providing research and development expertise in plasma technology.
- THEBEcoreInnovation partner. Healthcare organization focused on care and support services.
- Dutch Burns FoundationcoreInnovation partner and patient advocacy organization for burn wound care. Provides clinical expertise and patient perspective.
- EWMAcoreEuropean Wound Management Association. Innovation partner providing professional network and clinical expertise in wound care.
- Diabetes FondscoreDutch Diabetes Fund. Innovation partner addressing diabetic wound complications and patient advocacy.
- St. Antonius HospitalcoreInnovation partner and clinical healthcare provider. Major Dutch hospital providing clinical expertise and trial sites for wound care.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Plasmacure competitors and assessment
Company assessmentDirect peers
- Coldplasmatech (CPT): Coldplasmatech (CPT Plasma Medical) develops CE-certified cold atmospheric plasma medical devices for wound healing and dermatology. Direct competitor in cold plasma wound therapy with similar clinical positioning and European base.
- neoplas med GmbH: German medical technology company developing cold plasma-based devices for chronic wound care and dermatological indications. Closely overlapping technology platform and clinical use cases as Plasmacure's PLASOMA.
- terraplasma medical GmbH: Sibling company in the terraplasma group, develops cold atmospheric plasma devices (PlasmaDerm / PlasmaCube) for chronic and acute wounds. Direct peer in the cold plasma wound therapy category with German engineering roots.
Emerging players
- Adtec Healthcare: UK-based developer of cold plasma technology for wound care and infection control. Competes in adjacent cold plasma indications with overlapping chronic wound and dermatology applications.
- Organogenesis: US-listed regenerative medicine company focused on advanced wound care (Apligraf, Dermagraft) and surgical biologics. Comparable in addressing diabetic foot ulcers and venous leg ulcers with a clinically differentiated, premium-priced modality.
Broad incumbents
- Smith+Nephew: Global medical device incumbent with substantial Advanced Wound Management portfolio (NPWT, ACTICOAT, PICO). Represents the dominant hospital channel and competitive benchmark for any new wound modality entering the US.
- ConvaTec Group: Public medical products company with significant Advanced Wound Care franchise (AQUACEL, foam dressings). Deep relationships with hospital wound care teams and home care distributors globally.
- Coloplast: Danish medical device company with a large Wound Care business (Biatain, Comfeel). Serves hospitals, wound clinics, and home care with established reimbursement contracts across European markets where Plasmacure also operates.
- Mölnlycke Health Care: Swedish-owned wound care and surgical solutions provider (Mepilex, Mepitel, Avance NPWT system). Major incumbent in advanced wound care with strong European hospital footprint.
- Integra LifeSciences: US-listed medical technology company with a Tissue Technologies segment covering wound care (Integra Dermal Regeneration Template, PriMatrix). Comparable advanced biologics positioning and US commercialization scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Plasmacure social profiles
Digital presencePlasmacure compliance and trust
Trust signalCompliance2 records
Plasmacure financial estimates
Financial estimateRevenue estimate
Valuation estimate
Plasmacure leadership team
Management profileNumber of profiles
Profiles16 records
Plasmacure funding detail
Funding detailFunding overview
Funding rounds6 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Plasmacure M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Plasmacure
What does Plasmacure do?
Plasmacure develops and sells PLASOMA, a CE-certified medical device that uses Dual Plasma technology — combining cold plasma (controlled electrical discharge in air) with mild electrostimulation — to accelerate healing of chronic and complex wounds such as diabetic foot ulcers and venous leg ulcers in clinical and home-care settings. The offering is complemented by consumable cold plasma pads, service/maintenance contracts, and rental/try-out arrangements, sold primarily to healthcare providers, wound care centers, and through international distributors.
Is Plasmacure a public or private company?
Plasmacure is a private company. It is classified as venture growth investor backed and is currently operating.
When was Plasmacure founded?
Plasmacure was founded in 2015. It employs 1 to 10 people.
Where is Plasmacure based?
Plasmacure is headquartered in Eindhoven, Netherlands, in the Europe region.
How does Plasmacure make money?
Three revenue lines are on record. PLASOMA Medical Device Sales are the primary driver. The others are service and Maintenance and rental/Try-out.
Who are Plasmacure's main competitors?
Direct peers on record are Coldplasmatech (CPT), neoplas med GmbH and terraplasma medical GmbH. Emerging players are Adtec Healthcare and Organogenesis. Broad incumbents are Smith+Nephew, ConvaTec Group, Coloplast, Mölnlycke Health Care and Integra LifeSciences.
Does Plasmacure have an API?
No public API is recorded for Plasmacure.
What industry is Plasmacure in?
Plasmacure's product category is Advanced Wound Care Medical Devices. Its primary akta.pro industry code is HLAKACAN, Wound Care & Ulcer Management. Its NAICS code is 334510 and its SIC code is 3845.